- Conditions
- Bacterial Conjunctivitis
- Interventions
- SHP640, PVP-I 0.6%, Placebo
- Drug
- Lead sponsor
- Shire
- Industry
- Eligibility
- Not listed
- Enrollment
- 753 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 125
- States / cities
- Chandler, Arizona • Phoenix, Arizona • Prescott, Arizona + 97 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–8
of 8
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Allergic Conjunctivitis
- Interventions
- Dexamethasone 0.1% ophthalmic suspension, Olopatadine hydrochloride 0.1% ophthalmic solution, Inactive ingredients, used as placebo
- Drug · Other
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 180 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
- Conditions
- Cataract
- Interventions
- Tobramycin 0.3% / Dexamethasone 0.033% ophthalmic suspension, Tobramycin 0.3% / Dexamethasone 0.1% ophthalmic suspension (TOBRADEX)
- Drug
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 995 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
- Conditions
- Acute Adenoviral Conjunctivitis
- Interventions
- FST-100, FST-100 (Component #1), FST-100 Vehicle
- Drug
- Lead sponsor
- Shire
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 176 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 1
- States / cities
- Andover, Massachusetts
- Conditions
- Blepharokeratoconjunctivitis
- Interventions
- Loteprednol etabonate and tobramycin ophthalmic suspension, Tobramycin and dexamethasone ophthalmic suspension
- Drug
- Lead sponsor
- Bausch & Lomb Incorporated
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 276 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007
- U.S. locations
- 1
- States / cities
- High Point, North Carolina
- Conditions
- Acute Adenoviral Conjunctivitis
- Interventions
- FST-100 Ophthalmic Suspension, Placebo
- Drug
- Lead sponsor
- Shire
- Industry
- Eligibility
- 3 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 13
- States / cities
- Torrance, California • Colorado Springs, Colorado • Hamden, Connecticut + 10 more
- Conditions
- Adenoviral Conjunctivitis
- Interventions
- SHP640, Placebo
- Drug
- Lead sponsor
- Shire
- Industry
- Eligibility
- Not listed
- Enrollment
- 156 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 29
- States / cities
- Glendale, California • Los Angeles, California • Torrance, California + 25 more
- Conditions
- Adenoviral Conjunctivitis
- Interventions
- SHP640, PVP-I 0.6%, Placebo
- Drug · Other
- Lead sponsor
- Shire
- Industry
- Eligibility
- Not listed
- Enrollment
- 219 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 68
- States / cities
- Chandler, Arizona • Glendale, Arizona • Prescott, Arizona + 59 more